載入...
Low-density lipoprotein cholesterol lowering treatment: the current approach
In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase inhibitor...
Na minha lista:
| 發表在: | Lipids Health Dis |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201678/ https://ncbi.nlm.nih.gov/pubmed/32375792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-020-01275-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|